Previous reports showed that patients with EBV- or HPV-positive cancer had a better prognosis than those with the virus-negative cancer.5–7 Present finding may account for the better prognosis of the cancer patients with EBV or HPV infection due to the low PERK activity mediated by DNA tumor virus. The gene discussed is EIF2AK3; the disease is cancer.